Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors (Oncogene, (2020), 39, 45, (6935-6949), 10.1038/s41388-020-01479-6)

Yezi Zhu, Susan L. Dalrymple, Ilsa Coleman, S. Lilly Zheng, Jianfeng Xu, Jody E. Hooper, Emmanuel S. Antonarakis, Angelo M. De Marzo, Alan K. Meeker, Peter S. Nelson, William B. Isaacs, Samuel R. Denmeade, Jun Luo, W. Nathaniel Brennen, John T. Isaacs

Research output: Contribution to journalComment/debatepeer-review

Abstract

Unfortunaltely, an error occurred in Table 1. The corrected Table 1 is given below. The original version was corrected. (Table presented.).

Original languageEnglish (US)
Pages (from-to)3914-3916
Number of pages3
JournalOncogene
Volume40
Issue number22
DOIs
StatePublished - Jun 3 2021

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors (Oncogene, (2020), 39, 45, (6935-6949), 10.1038/s41388-020-01479-6)'. Together they form a unique fingerprint.

Cite this